多模态无创心血管筛查与性别特异性结局:Viborg筛查项目
丹麦Viborg筛查项目纳入67岁人群,邀请筛查颈动脉斑块、下肢动脉病、腹主动脉瘤、高血压、心律失常/缺血及糖尿病。
要点
- 多模态无创心血管筛查可降低67岁人群全因死亡风险(HR 0.76)
- 男性(HR 0.73)和女性(HR 0.82)全因死亡风险均降低
- 无既往心血管病者获益显著(HR 0.70),有既往心血管病者无显著获益(HR 0.97)
核心结论
- 多模态无创心血管筛查可降低67岁人群5年全因死亡率,性别分层后同样成立。
- 优先筛查无已知心血管病个体可能增强人群层面影响。
研究设计与样本
- 前瞻性人群为基础的丹麦Viborg筛查项目,干预为邀请所有67岁人群接受多模态无创筛查。
- 纳入2014-2019年前5年受邀者,对照为无筛查机会的67岁人群;采用倾向性评分匹配(1:3比例,最近邻匹配),按意向邀请原则用Cox比例风险模型分析。
主要发现
- 受邀者全因死亡372例(6.9%),对照1444例(8.9%),HR 0.76(95%CI 0.68-0.85;P < .001)。
- 全因死亡HR:男性0.73(95%CI 0.63-0.84),女性0.82(95%CI 0.68-0.98)。
- 无既往心血管病者全因死亡HR 0.70(95%CI 0.61-0.80),有既往心血管病者HR 0.97(95%CI 0.78-1.21)。
关键数值与推荐
- 心血管死亡HR 0.76(95%CI 0.56-1.03)。
- 主要不良心血管事件HR 1.10(95%CI 1.01-1.19)。
- 主要不良肢体事件HR 0.70(95%CI 0.50-0.98)。
- 需邀请49人可挽救1例生命。
临床怎么用
- 对67岁人群可考虑多模态无创心血管筛查以降低全因死亡风险。
- 筛查应优先覆盖无已知心血管病的个体以增强人群获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Cardiovascular screening has been shown to reduce mortality in trials involving men. This study evaluated the effect of cardiovascular screening in both sexes, with all-cause mortality as the primary outcome. METHODS: The Viborg Screening Program, a prospective, population-based study in Denmark, in which the intervention consisted of inviting all 67-year olds to screening for carotid plaque, lower extremity artery disease, abdominal aortic aneurysm, hypertension, cardiac arrhythmia/ischaemia, and diabetes mellitus. This cohort included invitees from the first 5 years (2014-2019). Controls were 67-year olds without screening access. Effects were evaluated using propensity score matching (1:3 ratio, nearest-neighbour matching) and analysed using Cox proportional hazards models under the intention-to-invite principle. Sex-stratified analyses of all-cause mortality were conducted post hoc. RESULTS: Among 5505 invitees, three died before inclusion and 4602 participated (83.6%). Ninety individuals lacked registry information. After matching, 5412 invitees and 16 236 controls were included. During a median follow-up of 5.8 years, 372 (6.9%) invitees and 1444 (8.9%) controls died [hazard ratio (HR) 0.76, 95% confidence interval (CI) 0.68-0.85; P < .001]. The number needed to invite to save one life was 49. The HR for cardiovascular mortality was 0.76 (95% CI 0.56-1.03), for major adverse cardiovascular events 1.10 (95% CI 1.01-1.19), and for major adverse limb events 0.70 (95% CI 0.50-0.98). All-cause mortality HRs were 0.73 (95% CI 0.63-0.84) for men, 0.82 (95% CI 0.68-0.98) for women, 0.70 (95% CI 0.61-0.80) for those without prior cardiovascular disease (CVD), and 0.97 (95% CI 0.78-1.21) for those with prior CVD. CONCLUSIONS: Multi-modality non-invasive cardiovascular screening reduced 5-year all-cause mortality among 67-year olds, also when stratified by sex. Prioritizing individuals without known CVD may enhance population-level impact.
引用
- Dahl M, Høgh A, Refsgaard J, et al. Multi-modality non-invasive cardiovascular screening and sex-specific outcomes: the Viborg Screening Program. Eur Heart J. 2026. PMID: 42048256. doi:10.1093/eurheartj/ehag309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。